Viewing Study NCT06591650


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-25 @ 5:59 AM
Study NCT ID: NCT06591650
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module